Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208


Background: Long-term therapy with MMF may induce IMPDH activity in peripheral blood mononuclear cells (MNC), reducing its immunosuppressive properties.
Material/Methods: IMPDH activity was measured in MNCs samples from 73 stable kidney transplant patients (median treatment time: 34 months, range: 3-75), before (t0) and 2 hours after (t2) MMF administration and monitored for up to 12 months. MMF treatment was combined with cyclosporine (CsA group) in 24 subjects, tacrolimus (TAC group) in 33, and sirolimus (SRL group) in 16. Samples from 95 healthy subjects were used as controls.
Results: IMPDH activity in healthy subjects was highly variable, mean 8.33±6.93 nmol/h/mg, with no relevant association with sex or age. In transplant recipients, during 12 months of MMF therapy, t0 IMPDH activity increased from 5.5±3.93 to 11.66±6.45 nmol/h/mg, with considerable intra- and interpatient variability (about 60%), and with no decrease in inhibition level (73.3%, range: 54.0-96.6). No significant intergroup differences were found. Mean concentrations of CsA, TAC, SRL and MPA were 142.4, 9.4, 12.9 ng/ml and 3.38 μg/ml. Four patients experienced acute rejection (AR) during the 12-month follow-up. IMPDH activity at t0 was increased during rejection versus non-rejection in 3 patients. No differences in enzyme inhibition levels were observed.
Conclusions: Despite the association found between IMPDH activity and AR, the high intrapatient variability affects its effectiveness as a predictive tool in long-term transplant outcomes. Further trials, also including pre-transplant data on both IMPDH expression and biological activity, are warranted to better assess the rule of IMPDH activity as biomarker for MPA effect in clinical practice.

Keywords: Mycophenolate Mofetil, combined therapy, Pulsed Doppler tissue imaging Dobutamine stress echocardiography

Add Comment 0 Comments

255 0

In Press

10 Nov 2023 : Original article  

Effects of Preservation of Donor Liver Gastroduodenal Artery on Post-Transplant Biliary Complications in 18...

Ann Transplant In Press; DOI: 10.12659/AOT.941699  

07 Nov 2023 : Original article  

Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Pos...

Ann Transplant In Press; DOI: 10.12659/AOT.942197  

06 Nov 2023 : Original article  

Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Pref...

Ann Transplant In Press; DOI: 10.12659/AOT.941456  

06 Nov 2023 : Original article  

Short-Term Monitoring of Graft Regeneration in Partial Liver Transplantation Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.941444  

Most Viewed Current Articles

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358